Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Core EBITDA Growth

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 34.3714.6689.44-31.9410.94

What is the latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA ?

The latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA is 34.37 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202534.37
Mar202414.66
Mar202389.44
Mar2022-31.94
Mar202110.94

How is Core EBITDA Growth of ASTRAZENECA PHARMA INDIA Trending?

Years Core EBITDA Growth % Change
Mar2025 34.37
134.45
Mar2024 14.66
-83.61
Mar2023 89.44
Positive
Mar2022 -31.94
Negative
Mar2021 10.94 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare Core EBITDA Growth ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹22,535.1 Cr -1.9% -1.3% 36.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,581.0 Cr -1.8% 4.1% -1.6% Stock Analytics
DIVIS LABORATORIES ₹167,051.0 Cr -2.8% -3.7% 2.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,367.0 Cr -0.2% -0.9% 12.9% Stock Analytics
CIPLA ₹120,289.0 Cr -2.1% -1.7% 0.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,421.0 Cr -2% 3.3% -0.6% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

-1.9%

-1.3%

36.1%

SENSEX

-0.8%

1%

3.2%


You may also like the below Video Courses